To further elucidate the role of p53 in the mechanism of action of GSK2830371 in NB cells, we used the CRISPR/Cas9-mediated genomic editing technology to generate a p53-knock out (KO) SH-SY5Y cell line. This evidence concerns the gene TP53 and neuroblastoma.